Creo Medical narrows operating loss as device revenue rises 45%
Creo Medical ($CREO) increased first-half revenue to £3.2 million from £2.2 million and reduced its underlying continuing operating loss to £4.9 million from £6.7 million. Underlying operating costs fell 15% to £7.9 million as the surgical-device company simplified its operating model. Management maintained confidence in full-year revenue growth of 50%–60%, supported by a traditionally stronger second half. The figures indicate improved commercial traction, although losses still exceed revenue a
0